Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myeloid-Derived Suppressor Cells | 1 | 2020 | 49 | 0.690 |
Why?
|
Prodrugs | 2 | 2020 | 59 | 0.680 |
Why?
|
Contrast Media | 7 | 2025 | 459 | 0.660 |
Why?
|
Coumarins | 2 | 2016 | 23 | 0.650 |
Why?
|
Placenta | 4 | 2025 | 487 | 0.580 |
Why?
|
Bibenzyls | 1 | 2016 | 1 | 0.530 |
Why?
|
Naphthalenes | 1 | 2016 | 37 | 0.520 |
Why?
|
Neoplasms | 3 | 2020 | 2753 | 0.450 |
Why?
|
Magnetic Resonance Imaging | 7 | 2025 | 3448 | 0.400 |
Why?
|
Antineoplastic Agents | 3 | 2016 | 1677 | 0.390 |
Why?
|
Nanoparticles | 3 | 2022 | 227 | 0.360 |
Why?
|
Tubulin | 4 | 2020 | 102 | 0.320 |
Why?
|
Ferrosoferric Oxide | 1 | 2025 | 26 | 0.240 |
Why?
|
Alzheimer Disease | 2 | 2022 | 755 | 0.230 |
Why?
|
Placenta Accreta | 1 | 2025 | 144 | 0.200 |
Why?
|
Triiodobenzoic Acids | 1 | 2021 | 28 | 0.180 |
Why?
|
X-Ray Microtomography | 1 | 2021 | 78 | 0.180 |
Why?
|
Plaque, Amyloid | 1 | 2020 | 61 | 0.180 |
Why?
|
Amyloid | 1 | 2020 | 64 | 0.170 |
Why?
|
Aortography | 1 | 2021 | 200 | 0.170 |
Why?
|
Stilbenes | 1 | 2020 | 34 | 0.170 |
Why?
|
Solubility | 2 | 2018 | 133 | 0.170 |
Why?
|
Computed Tomography Angiography | 1 | 2021 | 195 | 0.170 |
Why?
|
Aortic Rupture | 1 | 2021 | 118 | 0.170 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2020 | 102 | 0.170 |
Why?
|
Animals | 11 | 2025 | 33721 | 0.160 |
Why?
|
Fluorine | 1 | 2018 | 15 | 0.160 |
Why?
|
Mice | 9 | 2025 | 17546 | 0.160 |
Why?
|
Fluorocarbons | 1 | 2018 | 57 | 0.150 |
Why?
|
Aortic Aneurysm | 1 | 2021 | 224 | 0.150 |
Why?
|
Killer Cells, Natural | 1 | 2020 | 325 | 0.150 |
Why?
|
Mice, SCID | 2 | 2016 | 570 | 0.150 |
Why?
|
Aorta | 1 | 2021 | 533 | 0.140 |
Why?
|
Structure-Activity Relationship | 2 | 2016 | 570 | 0.140 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 547 | 0.140 |
Why?
|
Tubulin Modulators | 1 | 2015 | 10 | 0.130 |
Why?
|
Immunotherapy | 1 | 2020 | 658 | 0.120 |
Why?
|
Optical Imaging | 1 | 2016 | 66 | 0.120 |
Why?
|
Water | 1 | 2016 | 181 | 0.120 |
Why?
|
Drug Design | 1 | 2016 | 148 | 0.120 |
Why?
|
Breast | 1 | 2016 | 214 | 0.120 |
Why?
|
Cell Line, Tumor | 3 | 2016 | 3290 | 0.110 |
Why?
|
Benzocycloheptenes | 1 | 2013 | 1 | 0.110 |
Why?
|
Amino Acids | 1 | 2016 | 660 | 0.110 |
Why?
|
Disease Models, Animal | 4 | 2022 | 4282 | 0.090 |
Why?
|
Pregnancy | 4 | 2025 | 7092 | 0.080 |
Why?
|
Gadolinium | 2 | 2019 | 102 | 0.080 |
Why?
|
Liposomes | 2 | 2019 | 169 | 0.080 |
Why?
|
Breast Neoplasms | 2 | 2020 | 2480 | 0.070 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2020 | 96 | 0.070 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 4366 | 0.070 |
Why?
|
Mice, Transgenic | 2 | 2022 | 2441 | 0.060 |
Why?
|
Polymerization | 2 | 2015 | 14 | 0.060 |
Why?
|
Female | 6 | 2025 | 64882 | 0.060 |
Why?
|
Humans | 7 | 2025 | 122293 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 1679 | 0.060 |
Why?
|
Vimentin | 1 | 2022 | 65 | 0.050 |
Why?
|
Dilatation, Pathologic | 1 | 2021 | 93 | 0.050 |
Why?
|
Presenilin-1 | 1 | 2020 | 52 | 0.050 |
Why?
|
Macaca fascicularis | 1 | 2020 | 85 | 0.050 |
Why?
|
NADPH-Ferrihemoprotein Reductase | 1 | 2020 | 2 | 0.040 |
Why?
|
tau Proteins | 1 | 2022 | 189 | 0.040 |
Why?
|
A549 Cells | 1 | 2020 | 45 | 0.040 |
Why?
|
Colchicine | 1 | 2020 | 42 | 0.040 |
Why?
|
Early Diagnosis | 1 | 2021 | 178 | 0.040 |
Why?
|
Cell Hypoxia | 1 | 2020 | 95 | 0.040 |
Why?
|
Angiotensin II | 1 | 2021 | 161 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2020 | 382 | 0.040 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2020 | 121 | 0.040 |
Why?
|
Blood Volume | 1 | 2019 | 79 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2022 | 523 | 0.040 |
Why?
|
Diet, High-Fat | 1 | 2021 | 206 | 0.040 |
Why?
|
Placentation | 1 | 2019 | 53 | 0.040 |
Why?
|
Limit of Detection | 1 | 2018 | 58 | 0.040 |
Why?
|
Signal-To-Noise Ratio | 1 | 2018 | 39 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 56 | 0.040 |
Why?
|
Phantoms, Imaging | 1 | 2018 | 126 | 0.040 |
Why?
|
Mice, Inbred BALB C | 1 | 2020 | 979 | 0.040 |
Why?
|
Models, Animal | 1 | 2019 | 465 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2020 | 745 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 2080 | 0.030 |
Why?
|
Molecular Docking Simulation | 1 | 2015 | 113 | 0.030 |
Why?
|
Gestational Age | 1 | 2019 | 1115 | 0.030 |
Why?
|
Disease Progression | 1 | 2021 | 1990 | 0.030 |
Why?
|
Rats | 1 | 2020 | 3657 | 0.030 |
Why?
|
Biomarkers | 1 | 2022 | 2933 | 0.030 |
Why?
|
Molecular Structure | 1 | 2013 | 286 | 0.030 |
Why?
|
Time Factors | 1 | 2021 | 6182 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2013 | 2311 | 0.020 |
Why?
|
Male | 2 | 2021 | 59520 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2022 | 15853 | 0.010 |
Why?
|
Adult | 1 | 2025 | 28732 | 0.010 |
Why?
|